Andere talen Pharmadrug Inc.

Aandelen

PHRX

CA71716W2040

Beurs gesloten - Canadian Securities Exchange Andere beurzen 21:14:13 02-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,03 ^CAD	0,00%		0,00%	-45,45%

13/03	SecureDose van Pharmadrug kondigt de indiening aan van een Amerikaans voorlopig patent voor een productiemethode voor biosynthetische farmaceutische cocaïne	CI
28/02	PharmaDrug Inc kondigt veranderingen in de Raad van Bestuur aan	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

PharmaDrug Announces Director Appointment and Resignation	02/05
PharmaTher's Sairiyo Therapeutics Completes Regulatory Package For Phase 1 Study of Reformulated Cepharanthine in Australia	01/05
PharmaDrug's Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine	01/05
PharmaDrug's SecureDose Announces the Advancement of Process Development of Its Biosynthetic Formulation of Pharmaceutical Grade Cocaine	16/04
PharmaTher Updated on its Priority Original Abbreviated New Drug Application for Ketamine	16/04
Pharmadrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine	13/03
PharmaDrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine	13/03
PharmaDrug Inc Announces Board Changes	28/02
PharmaDrug Appoints Current Board Member Dr. David Kideckel as Chairman	27/02
PharmaTher Provides Update For PD-001	21/02
PharmaDrug's Sairiyo Successfully Demonstrates Ability to Manufacture Cepharanthine (PD-001) for Human Clinical Studies	14/02
Pharmadrug Inc. Announces Marketing and Distribution Services Agreement with Outside the Box Capital Inc	12/02
PharmaDrug Inc. Engages Investor Relations and Marketing Service Providers	12/02
PharmaDrug Inc. Announces Successful Closing of Non-Brokered Private Placement	08/02
Pharmadrug Inc. announced that it has received CAD 0.326 million in funding	08/02
PharmaDrug Inc. Announces Proposed Non-Brokered Private Placement	01/02
Pharmadrug Inc. announced that it expects to receive CAD 0.326 million in funding	01/02
PharmaDrug CEO Provides Vision for Securedose Acquisition	13/12
PharmaDrug Inc. Completes Debt Restructuring	15/11
PharmaDrug Inc. Announces Grant of Stock Options	08/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Pharmadrug Inc.

Aandelen

PHRX

CA71716W2040

Andere talen

Filters